Cresco Labs Balance Sheet Health
Financial Health criteria checks 3/6
Cresco Labs has a total shareholder equity of $420.0M and total debt of $424.7M, which brings its debt-to-equity ratio to 101.1%. Its total assets and total liabilities are $1.4B and $940.1M respectively. Cresco Labs's EBIT is $88.8M making its interest coverage ratio 1.5. It has cash and short-term investments of $123.2M.
Key information
101.1%
Debt to equity ratio
US$424.65m
Debt
Interest coverage ratio | 1.5x |
Cash | US$123.16m |
Equity | US$419.97m |
Total liabilities | US$940.09m |
Total assets | US$1.36b |
Recent financial health updates
Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden
Jun 19Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt
Jan 26Is Cresco Labs (CSE:CL) Using Too Much Debt?
Sep 22Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet
Jan 25We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt
Aug 22Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt
Oct 06Recent updates
Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 34%?
Jul 17Here's Why Cresco Labs (CSE:CL) Has A Meaningful Debt Burden
Jun 19Cresco Labs Inc.'s (CSE:CL) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 19Cresco Labs Inc. (CSE:CL) Released Earnings Last Week And Analysts Lifted Their Price Target To CA$5.41
Mar 16Investors Don't See Light At End Of Cresco Labs Inc.'s (CSE:CL) Tunnel And Push Stock Down 32%
Mar 03Cresco Labs (CSE:CL) Seems To Be Using A Lot Of Debt
Jan 26Risks To Shareholder Returns Are Elevated At These Prices For Cresco Labs Inc. (CSE:CL)
Jan 04Is Cresco Labs (CSE:CL) Using Too Much Debt?
Sep 22Some Confidence Is Lacking In Cresco Labs Inc. (CSE:CL) As Shares Slide 33%
Aug 11Cresco Labs (CSE:CL) Has A Somewhat Strained Balance Sheet
Jan 25Are Investors Undervaluing Cresco Labs Inc. (CSE:CL) By 24%?
Dec 13We Think Cresco Labs (CSE:CL) Is Taking Some Risk With Its Debt
Aug 22Estimating The Intrinsic Value Of Cresco Labs Inc. (CSE:CL)
May 23Cresco Labs Inc. (CSE:CL) Analysts Are Way More Bearish Than They Used To Be
Mar 24Estimating The Fair Value Of Cresco Labs Inc. (CSE:CL)
Feb 02Cresco Labs Inc. (CSE:CL) Shares Could Be 41% Below Their Intrinsic Value Estimate
Oct 27Cresco Labs (CSE:CL) Takes On Some Risk With Its Use Of Debt
Oct 06Financial Position Analysis
Short Term Liabilities: CL's short term assets ($285.1M) exceed its short term liabilities ($209.2M).
Long Term Liabilities: CL's short term assets ($285.1M) do not cover its long term liabilities ($730.9M).
Debt to Equity History and Analysis
Debt Level: CL's net debt to equity ratio (71.8%) is considered high.
Reducing Debt: CL's debt to equity ratio has increased from 0% to 101.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CL is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 12.6% per year.